First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

When Nikki Myers found the lump in her neck last fall, she visited an urgent care clinic. Doctors suspected Myers had a chest infection that caused an inflamed lymph node and performed a CT scan. But ...

Ovarian cancer. It's often called the silent killer because its symptoms can be so easy to overlook. It's one of the top leading causes of cancer deaths among women. Yet awareness, early detection, ...

Cancer treatments, while effective, often have severe side effects that significantly impact patients' quality of life, such as chronic diarrhea. Long-term cancer therapies are increasingly used to ...

Terri Baker was diagnosed with stage 4 ovarian cancer in September. Today, the cancer is undetectable. When Terri Baker walked into an emergency room for blood in her urine, doctors diagnosed her with ...

Secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves overall survival in ...

It's a cancer that's known as the "silent killer" because there's no early warning system, but promising new research could be the difference between life or death for those diagnosed with ovarian ...

The Ovarian Cancer Coalition of Central SC (OCC) will hold the annual butterfly release for ovarian cancer September 18, 2025 (5:30 pm) at the SC State House to raise awareness of this deadly disease.

Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...